ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,615.35
      0.55%
      US Tech 100
      19,804.00
      0.64%
      Dow Jones
      40,000.90
      0.62%
      Brent Oil
      84.57
      0.00%
      Bitcoin
      60,032.27
      1.35%
      Registration Strip Icon for monitor Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Aeterna Zentaris Inc (AEZS)

      7. Aeterna Zentaris Inc (AEZS) News

      AEZS

      Aeterna Zentaris (AEZS)

      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:AEZS
      DateTimeSourceHeadlineSymbolCompany
      04/17/20078:30AMPR Newswire (US)AEterna Zentaris Discloses In Vivo Data for its GHRH Antagonist JMR-132 at the AACR Annual Meeting in Los AngelesNASDAQ:AEZS
      04/16/20078:30AMPR Newswire (US)AEterna Zentaris Discloses First In Vitro Data for its PI3K Inhibitors at the AACR Annual Meeting in Los AngelesNASDAQ:AEZS
      04/13/200711:31AMPR Newswire (US)AEterna Zentaris To Present First In Vitro Data for PI3K Inhibitors and In Vivo Results for a GHRH Antagonist at the AACR AnnualNASDAQ:AEZS
      04/05/200710:00AMPR Newswire (US)AEterna Zentaris to Present at Upcoming CIBC World Markets Annual Biotechnology & Specialty Pharmaceuticals Conference in New YoNASDAQ:AEZS
      03/26/20079:58AMPR Newswire (US)AEterna Zentaris Announces Appointment of New President and CEONASDAQ:AEZS
      03/22/20077:30AMPR Newswire (US)AEterna Zentaris Reports Positive Results with Cetrorelix in BPH for Japanese Phase 2a TrialNASDAQ:AEZS
      03/21/20079:00AMPR Newswire (US)AEterna Zentaris to Host Live Webcast of Analyst and Investor Meeting TodayNASDAQ:AEZS
      03/05/20077:30AMPR Newswire (US)AEterna Zentaris Reports Fourth Quarter and Full-Year 2006 Financial and Operating ResultsNASDAQ:AEZS
      02/27/20077:30AMPR Newswire (US)AEterna Zentaris to Announce Fourth Quarter and Full-Year 2006 Financial and Operating Results on March 5, 2007NASDAQ:AEZS
      02/12/20078:20AMPR Newswire (US)AEterna Zentaris To File Restated Interim 2006 Third Quarter Financials - Net loss for the third quarter and the nine-month periNASDAQ:AEZS
      02/05/20077:30AMPR Newswire (US)AEterna Zentaris to Present at Upcoming BIO CEO & Investor Conference in New YorkNASDAQ:AEZS
      01/26/20077:00AMPR Newswire (US)AEterna Zentaris Discloses New In Vivo Data for ZEN-012 at the 7th Joint Conference of the AACR and JCANASDAQ:AEZS
      01/08/20077:30AMPR Newswire (US)AEterna Zentaris Initiates Phase 1 Trial for ZEN-012, a new small molecule oral anti-cancer drugNASDAQ:AEZS
      01/08/20077:00AMPR Newswire (US)AEterna Zentaris Initiates First Study of Phase 3 Program with Cetrorelix in BPH - 600 Patient Trial Conducted in the United StaNASDAQ:AEZS
      01/03/20079:08AMPR Newswire (US)AEterna Zentaris Completes Distribution of Remaining Shares of Atrium BiotechnologiesNASDAQ:AEZS
      12/15/200612:08PMPR Newswire (US)AEterna Zentaris Shareholders Approve Reduction in Stated Capital and Distribution of Remaining Shares of Atrium BiotechnologiesNASDAQ:AEZS
      12/11/200610:45AMPR Newswire (US)AEterna Zentaris Announces Positive Interim Phase 2 Data on Perifosine (KRX-0401) in Patients with Relapsed and Refractory MultiNASDAQ:AEZS
      12/11/200610:35AMPR Newswire (US)Keryx Biopharmaceuticals, Inc. Announces Positive Interim Phase II Data on KRX-0401 (Perifosine) in Patients with Relapsed and RNASDAQ:AEZS
      12/11/20067:30AMPR Newswire (US)AEterna Zentaris Participating on Oncology Panel at Upcoming RBC Capital Markets Healthcare Conference in New YorkNASDAQ:AEZS
      12/07/20069:00AMPR Newswire (US)AEterna Zentaris Announces Poster Presentations Highlighting Clinical and Preclinical Activity of Perifosine (KRX-0401) at the ANASDAQ:AEZS
      12/07/20068:29AMPR Newswire (US)Keryx Biopharmaceuticals, Inc. Announces Poster Presentations Highlighting Clinical and Pre-Clinical Activity of KRX-0401 (PerifNASDAQ:AEZS
      12/07/20068:29AMPR Newswire (US)Keryx Biopharmaceuticals, Inc. Announces Poster Presentations Highlighting Clinical and Pre-Clinical Activity of KRX-0401 (PerifNASDAQ:AEZS
      11/29/20067:30AMPR Newswire (US)AEterna Zentaris to Initiate Phase 3 Program with Cetrorelix in BPHNASDAQ:AEZS
      11/27/20068:30AMPR Newswire (US)AEterna Zentaris to Webcast Analyst Meeting in Toronto on November 29, 2006NASDAQ:AEZS
      11/27/20067:30AMPR Newswire (US)AEterna Zentaris Reports Positive Top Line Phase 1 Results for AN-152 in Patients with Gynaecological and Breast CancersNASDAQ:AEZS
      11/27/20067:30AMPR Newswire (US)AEterna Zentaris Reports Positive Top Line Phase 1 Results for AN-152 in Patients with Gynaecological and Breast CancersNASDAQ:AEZS
      11/13/20068:30AMPR Newswire (US)AEterna Zentaris Presents Detailed Positive Phase 2 Data on Ozarelix in Prostate Cancer at SIU Meeting in Cape Town, South AfricNASDAQ:AEZS
      11/13/20067:30AMPR Newswire (US)Aeterna Zentaris Reports 2006 Third Quarter ResultsNASDAQ:AEZS
      11/07/20067:30AMPR Newswire (US)AEterna Zentaris Will Disclose 2006 Third Quarter Financial and Operating Results on November 13NASDAQ:AEZS
      10/31/20067:00AMPR Newswire (US)AEterna Zentaris to Present at Upcoming CIBC World Markets Conference and Rodman & Renshaw's 8th Annual Healthcare Conference inNASDAQ:AEZS
       Showing the most relevant articles for your search:NASDAQ:AEZS